Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
- PMID: 33214947
- PMCID: PMC7671171
- DOI: 10.7759/cureus.11019
Correlation of Fasting Lipid Profile in Patients With Chronic Liver Disease: A Descriptive Cross-Sectional Study in Tertiary Care Hospital
Abstract
Introduction: Chronic liver disease (CLD) is a term used to describe a wide spectrum of disorders, including idiopathic, infectious, genetic, drug-induced, toxin-induced, and autoimmune disorders. The common consequence of chronic damage to the liver is cirrhosis. Cirrhotic patients are further classified by their severity based on the Child-Pugh scoring system. Currently, Child-Pugh scoring consists of ascites, hepatic encephalopathy (HE), prothrombin time, serum albumin level, and total bilirubin level. Lipid panel in CLD is a great marker in determining the severity of CLD. Method and methodology: It was a descriptive cross-sectional study conducted at a tertiary care hospital. A sample size of 122 was calculated by using a RaoSoft Digital Sample Size Calculator (RaoSoft, Inc., Seattle, WA) in which we used 5% as a margin of error, 95% as confidence interval (CI), 178 as population size, and response distribution as 50%. Non-complicated CLD patients having age in between 15 and 80 years with no cirrhotic complications including HE, spontaneous bacterial peritonitis, hepato-pumonary, or hepato-renal syndrome were included in our study; the rest of the CLD patients were excluded from our study.
Results: The mean age of the study population was 47.09 ± 12.30 years with more than half of the patients lying among the age group 25-50 years. The study population included 76% of males (n=93) and 24% of females (n=29), with a mean age of females higher than the males. Diabetes mellitus (58.19%) was the most frequent comorbidity associated with CLD in subjects included in our study. Parameters of lipid panel were decreased exponentially as the severity of CLD increases from Child score A to C. Total cholesterol, low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), and triglyceride (TG) level decreased as the severity increases in our study. The mean model for end-stage liver disease (MELD) score increased as per hypothesized as the severity increases from Child score A to Child score C, respectively.
Conclusion: Our study concluded that as the severity of CLD increases from Child class A to Child class C, the lipid panel profile decreases exponentially which proved the idea that had been hypothesized at the beginning of our study.
Keywords: chronic liver disease; correlation; descriptive; lipid panel; tertiary care.
Copyright © 2020, Tauseef et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study.Cureus. 2020 Dec 26;12(12):e12294. doi: 10.7759/cureus.12294. Cureus. 2020. PMID: 33520498 Free PMC article.
-
Lipid Profile as an Indicator of Severity in Cirrhosis of Liver: Hospital based Cross-sectional Study.J Assoc Physicians India. 2023 Mar;71(3):11-12. doi: 10.5005/japi-11001-0210. J Assoc Physicians India. 2023. PMID: 37354505
-
Correlation of Serum Prolactin Levels With Chronic Liver Disease Severity in a Tertiary Care Hospital in Eastern India.Cureus. 2025 Jan 8;17(1):e77164. doi: 10.7759/cureus.77164. eCollection 2025 Jan. Cureus. 2025. PMID: 39925608 Free PMC article.
-
Update on blood-based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience.JGH Open. 2021 Oct 30;5(11):1250-1256. doi: 10.1002/jgh3.12667. eCollection 2021 Nov. JGH Open. 2021. PMID: 34816010 Free PMC article. Review.
-
Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease.Brain Sci. 2021 Jan 22;11(2):142. doi: 10.3390/brainsci11020142. Brain Sci. 2021. PMID: 33499194 Free PMC article. Review.
Cited by
-
Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2022 Dec 14;9:1279-1298. doi: 10.2147/JHC.S392051. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36545268 Free PMC article. Review.
-
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?World J Gastroenterol. 2024 Jan 14;30(2):128-136. doi: 10.3748/wjg.v30.i2.128. World J Gastroenterol. 2024. PMID: 38312119 Free PMC article. Review.
-
Effects of Preoperative Oral Carbohydrate on Cirrhotic Patients under Endoscopic Therapy with Anesthesia: A Randomized Controlled Trial.Biomed Res Int. 2021 Sep 8;2021:1405271. doi: 10.1155/2021/1405271. eCollection 2021. Biomed Res Int. 2021. PMID: 34540991 Free PMC article. Clinical Trial.
-
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.Clin Mol Hepatol. 2022 Oct;28(4):773-789. doi: 10.3350/cmh.2021.0383. Epub 2022 Aug 8. Clin Mol Hepatol. 2022. PMID: 35934813 Free PMC article. Review.
-
The Pattern of Dyslipidemia in Chronic Liver Disease Patients.Cureus. 2021 Feb 10;13(2):e13259. doi: 10.7759/cureus.13259. Cureus. 2021. PMID: 33728198 Free PMC article.
References
-
- Dyslipidemia and hyperinsulinemia in children and adolescents with chronic liver disease: relation to disease severity. El-Kabbany ZA, Hamza RT, Ibrahim SA, Mahmoud NH. Int J Adolesc Med Health. 2014;26:195–201. - PubMed
-
- Epidemiology and clinical evolution of liver cirrhosis in Singapore. Chang PE, Wong GW, Li JW, Lui HF, Chow WC, Tan CK. https://pubmed.ncbi.nlm.nih.gov/26292950/ Ann Acad Med Singap. 2015;44:218–225. - PubMed
-
- Efficacy of a chronic disease management model for patients with chronic liver failure. Wigg AJ, McCormick R, Wundke R, Woodman RJ. Clin Gastroenterol Hepatol. 2013;11:850–858. - PubMed
-
- Burden of liver diseases in the world. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. J Hepatol. 2019;70:151–171. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous